LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Comparison of the Effects of Haloperidol, Metoclopramide, Dexmedetomidine and Ginger on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy.

    Naemi, Amir Reza / Kashanitabar, Vahid / Kamali, Alireza / Shiva, Ashkan

    Journal of medicine and life

    2020  Volume 13, Issue 2, Page(s) 206–210

    Abstract: Nausea is a mental sensation of unease and discomfort before vomiting. Vomiting refers to the return of the contents of the upper gastrointestinal tract to the mouth caused by contractions of chest and abdomen muscles. Postoperative nausea and vomiting ... ...

    Abstract Nausea is a mental sensation of unease and discomfort before vomiting. Vomiting refers to the return of the contents of the upper gastrointestinal tract to the mouth caused by contractions of chest and abdomen muscles. Postoperative nausea and vomiting is an unpleasant experience with high treatment costs. Therefore, this study aimed to compare the effects of haloperidol, metoclopramide, dexmedetomidine, and ginger on postoperative nausea and vomiting after laparoscopy. This double-blind clinical trial was performed on all laparoscopy candidates at Valiasr hospital, Arak, Iran. The patients were randomly divided into four groups (haloperidol, metoclopramide, dexmedetomidine and ginger), and all patients underwent general anesthesia using fentanyl, midazolam, atracurium, and propofol. After intubation, tube fixation, and stable hemodynamic conditions, the patients received four ginger capsules with a hint of lemon. A group of patients received 25 μg of dexmedetomidine. In the Plasil group, 10 mg of metoclopramide was given 30 minutes before the completion of surgery. In addition, 0.5 cc of haloperidol (5 mg) was administered to a group of patients. Heart rate, blood pressure, and oxygen saturation were recorded from the beginning of surgery, every 15 minutes until the end of the surgery. Furthermore, the occurrence of nausea and vomiting was recorded during recovery, 2 and 4 hours after surgery. Data were then analyzed using the SPSS software v.23. Eighty-eight patients were enrolled in the study. The youngest and the oldest were 30 years and 70 years old, respectively, and the mean age was 48.02 ± 9.31 years. Moreover, the number of women in the four groups was higher than that of men. Blood pressure in the dexmedetomidine group was lower than the other four groups (P <0.05). The lowest heart rate was observed in the haloperidol group, while the highest heart rate was seen in the plasil group (P <0.05). The occurrence of vomiting and nausea was not significantly different between the four groups (P <0.05). Our results showed no significant difference in postoperative nausea and vomiting between the four drugs. Due to the hemodynamic changes induced by each drug, it is best to use these drugs based on the patient's condition. Ginger is also a herbal remedy that has fewer side effects, and this drug can be a good option for patients when there is no contraindication.
    MeSH term(s) Adult ; Aged ; Blood Pressure/drug effects ; Cholecystectomy, Laparoscopic/adverse effects ; Dexmedetomidine/pharmacology ; Dexmedetomidine/therapeutic use ; Double-Blind Method ; Female ; Zingiber officinale/chemistry ; Haloperidol/pharmacology ; Haloperidol/therapeutic use ; Humans ; Iran ; Male ; Metoclopramide/pharmacology ; Metoclopramide/therapeutic use ; Middle Aged ; Oxygen/metabolism ; Plant Extracts/therapeutic use ; Postoperative Nausea and Vomiting/drug therapy ; Postoperative Nausea and Vomiting/etiology
    Chemical Substances Plant Extracts ; Dexmedetomidine (67VB76HONO) ; Haloperidol (J6292F8L3D) ; Metoclopramide (L4YEB44I46) ; Oxygen (S88TT14065)
    Language English
    Publishing date 2020-07-31
    Publishing country Romania
    Document type Comparative Study ; Journal Article ; Randomized Controlled Trial
    ZDB-ID 2559353-5
    ISSN 1844-3117 ; 1844-3117 ; 1844-3109
    ISSN (online) 1844-3117
    ISSN 1844-3117 ; 1844-3109
    DOI 10.25122/jml-2019-0070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Moderately hyperglycemia as an independent prognostic factor for the worse outcome of COVID-19.

    Nateghi, Saeed / Gomari, Mohammad Mahmoudi / Roudsari, Yousef Jalali / Foroughi, Alireza / Mansouri, Fariba / Shiva, Ashkan / Nasrollahizadeh, Ali / Nasiri, Zohreh / Faraji, Neda

    Primary care diabetes

    2022  Volume 16, Issue 3, Page(s) 361–364

    Abstract: Background: Blood sugar (BS) has been proposed as a prognostic factor for COVID-19. In this historical cohort study we evaluated the association between admission time BS and COVID-19 outcome.: Methods: First, hospitalized COVID-19 patients were ... ...

    Abstract Background: Blood sugar (BS) has been proposed as a prognostic factor for COVID-19. In this historical cohort study we evaluated the association between admission time BS and COVID-19 outcome.
    Methods: First, hospitalized COVID-19 patients were divided into three groups; Non-diabetic patients with BS < 140 mg/dl (N = 394), non-diabetic patients with BS ≥ 140 mg/dl (N = 113) and diabetic patients (N = 315). Mortality, ICU admission, and length of hospital stay were compared between groups and odds ratio was adjusted using logistic regression.
    Results: After adjustment with pre-existing conditions and drugs, it was shown that non-diabetic patients with BS ≥ 140 mg/dl are at increased risk of mortality (aOR 1.89 (0.99-3.57)) and ICU admission (aOR 2.62 (1.49-4.59)) even more than diabetic patients (aOR 1.72 (1.07-2.78) for mortality and aOR 2.28 (1.47-3.54) for ICU admission.
    Conclusions: Admission time hyperglycemia predicts worse outcome of COVID-19 and BS ≥ 140 mg/dl is associated with a markedly increase in ICU admission and mortality.
    MeSH term(s) Blood Glucose ; COVID-19 ; Cohort Studies ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/epidemiology ; Diabetes Mellitus/therapy ; Humans ; Hyperglycemia/diagnosis ; Hyperglycemia/epidemiology ; Prognosis ; Retrospective Studies
    Chemical Substances Blood Glucose
    Language English
    Publishing date 2022-03-09
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2273997-X
    ISSN 1878-0210 ; 1751-9918
    ISSN (online) 1878-0210
    ISSN 1751-9918
    DOI 10.1016/j.pcd.2022.03.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top